Chinese medicament for treating osseous tuberculosis

Abstract

The invention discloses a Chinese medicament for treating osseous tuberculosis, which consists of the following raw material medicaments in part by weight: 20 to 30 parts of long-nosed pit viper, 20 to 30 parts of blister beetle, 10 to 15 parts of centipede, 10 to 15 parts of scorpion, 10 to 15 parts of cornu cervi degelatinatum, 10 to 15 parts of white mulberry root-bark, 10 to 15 parts of Chinese taxillus twig, 10 to 15 parts of mulberry leaf, 10 to 15 parts of sappan wood, 5 to 10 parts of prepared common monkshood daughter root, 5 to 10 parts of himalayan teasel root, 5 to 10 parts of Szechuan lovage rhizome, 5 to 10 parts of rhubarb, 5 to 10 parts of amur corktree bark, 16 to 32 parts of thesium, 5 to 10 parts of bletilla, 5 to 10 parts of myrrh and 8 to 18 parts of bupleurum. The Chinese medicament for treating the osseous tuberculosis is completely prepared from pure Chinese medicinal herbs, has obvious curative effects on the osseous tuberculosis, and reduces pains of patients in the process of treatment. The Chinese medicament has an ancestral secret formula with near two hundred years of history. Clinical treatment proves that the Chinese medicament has a curative rate of the osseous tuberculosis of over 99 percent, and no toxic or side effects.

Description

technical field

[0001] The invention relates to a traditional Chinese medicine for treating bone tuberculosis. Background technique

[0002] Bone tuberculosis is a purulent and destructive lesion caused by Mycobacterium tuberculosis invading bones or joints. Traditional Chinese medicine is called bone tuberculosis because it occurs in the bones or joints and consumes qi, blood and body fluid, resulting in thin body in the later stage, decay of righteousness, lingering and difficult to heal. And because after the primary disease becomes pus, it can flow to other places to form a cold abscess, and the pus is accompanied by flocculent phlegm after ulceration, so it is also called phlegm. The disease is more common in pre-children and adolescents. Most patients are under the age of 30. The incidence rate is highest among school-age children under 10 years old, especially 3-5 years old. Most of the diseased sites are in the bones or joints that are heavily loaded, active, and...